News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi Opens 30-day Downside Catalyst Watch on GIANT BIOGENE (02367.HK)
GIANT BIOGENE (02367.HK) opened 8.6% lower today, and bottomed at $68.75. It closed at $74 at midday, down 3.52%, with 18.7421 million shares traded, involving $1.367 billion.Citi ...
Reset
Send
The window will close in 5 seconds
<Research>Citi Opens 30-day Downside Catalyst Watch on GIANT BIOGENE (02367.HK)
Close
Recommend
9
Positive
9
Negative
6
 
SHORT SELL
 
STOCK INFO

GIANT BIOGENE (02367.HK)  -0.600 (-0.862%)    Short selling $61.75M; Ratio 11.438%   opened 8.6% lower today, and bottomed at $68.75. It closed at $74 at midday, down 3.52%, with 18.7421 million shares traded, involving $1.367 billion.

Citi Research issued a research report opening a 30-day downside catalyst watch on GIANT BIOGENE for allegations made by a KOL against GIANT BIOGENE's core product, Comfy Collagen Stick.

Related NewsCiti Initiates Coverage on MAO GEPING w/ Rating Buy & TP HKD130
Despite GIANT BIOGENE's quick response and denial of the allegations, Citi Research was concerned that such negative publicity may affect consumer sentiment, which in turn could jeopardize Comfy's 618 performance.

The broker believed that the development and impact of the incident will depend on the subsequent PR actions taken by GIANT BIOGENE to protect consumer confidence.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-28 12:25.)

AAStocks Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.